Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 5/20 | 0.52 |
| ▸ | MME | P08473 | 1/20 | 0.52 |
| ▸ | CPA1 | P15085 | 1/20 | 0.52 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 11/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 9/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29472198 | 0.89 | OPRD1 (0.58) | ACEMMECPA1ACE2OPRD1 | |
| SCHEMBL29472194 | 0.87 | CTSS (0.54) | ACEMMECPA1ACE2OPRD1 | |
| SCHEMBL30887562 | 0.86 | OPRD1 (0.64) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29472195 | 0.83 | F2 (0.52) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29994099 | 0.82 | OPRD1 (0.65) | ACEMMECPA1ACE2OPRD1 | |
| SCHEMBL31257021 | 0.82 | OPRD1 (0.56) | OPRD1OPRM1OPRK1 | |
| SCHEMBL13402647 | 0.81 | ACE (0.58) | ACEMMECPA1ACE2 | |
| SCHEMBL29472190 | 0.81 | OPRD1 (0.54) | OPRD1OPRM1OPRK1 | |
| SCHEMBL31256991 | 0.80 | OPRD1 (0.58) | OPRD1OPRM1OPRK1 | |
| SCHEMBL31090007 | 0.79 | ACE (0.61) | ACEMMECPA1ACE2OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115353546-B | Preparation and application of oligopeptide modified bisindolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2024-10-08 | — | — | CN | disclosed |
| CN-115353546-A | Preparation and application of oligopeptide-modified bis-indolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2022-11-18 | — | — | CN | disclosed |